blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3950063

EP3950063 - NOVEL AZAINDOLE DERIVATIVE [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  06.10.2023
Database last updated on 09.07.2024
FormerRequest for examination was made
Status updated on  07.01.2022
FormerThe international publication has been made
Status updated on  09.10.2020
Most recent event   Tooltip06.10.2023Application deemed to be withdrawnpublished on 08.11.2023  [2023/45]
Applicant(s)For all designated states
KOWA COMPANY, LTD.
6-29, Nishiki 3-chome
Naka-ku
Nagoya-shi
Aichi 460-8625 / JP
[2022/06]
Inventor(s)01 / WATANABE, Gen
c/o KOWA COMPANY, LTD., Tokyo New Drug Research
Laboratories, 2-17-43, Noguchi-cho
Higashimurayama-shi, Tokyo 189-0022 / JP
02 / MORIMOTO, Toshiharu
c/o KOWA COMPANY, LTD., Tokyo New Drug Research
Laboratories, 2-17-43, Noguchi-cho
Higashimurayama-shi, Tokyo 189-0022 / JP
03 / IWATA, Akira
c/o KOWA COMPANY, LTD., Tokyo New Drug Research
Laboratories, 2-17-43, Noguchi-cho
Higashimurayama-shi, Tokyo 189-0022 / JP
04 / SASAKI, Hirotaka
c/o KOWA COMPANY, LTD., Tokyo New Drug Research
Laboratories, 2-17-43, Noguchi-cho
Higashimurayama-shi, Tokyo 189-0022 / JP
05 / OGAMINO, Takahisa
c/o KOWA COMPANY, LTD., Tokyo New Drug Research
Laboratories, 2-17-43, Noguchi-cho
Higashimurayama-shi, Tokyo 189-0022 / JP
06 / USUDA, Kosuke
c/o KOWA COMPANY, LTD., Tokyo New Drug Research
Laboratories, 2-17-43, Noguchi-cho
Higashimurayama-shi, Tokyo 189-0022 / JP
07 / OKUDA, Ayumu
c/o KOWA COMPANY, LTD., Tokyo New Drug Research
Laboratories, 2-17-43, Noguchi-cho
Higashimurayama-shi, Tokyo 189-0022 / JP
08 / ISHIWATA, Hiroyuki
c/o KOWA COMPANY, LTD., Tokyo New Drug Research
Laboratories, 2-17-43, Noguchi-cho
Higashimurayama-shi, Tokyo 189-0022 / JP
09 / TABUNOKI, Yuichiro
c/o KOWA COMPANY, LTD., Tokyo New Drug Research
Laboratories, 2-17-43, Noguchi-cho
Higashimurayama-shi, Tokyo 189-0022 / JP
10 / NISHII, Keigo
c/o KOWA COMPANY, LTD., Tokyo New Drug Research
Laboratories, 2-17-43, Noguchi-cho
Higashimurayama-shi, Tokyo 189-0022 / JP
[N/P]
Former [2022/06]01 / WATANABE, Gen
Higashimurayama-shi, Tokyo 189-0022 / JP
02 / MORIMOTO, Toshiharu
Higashimurayama-shi, Tokyo 189-0022 / JP
03 / IWATA, Akira
Higashimurayama-shi, Tokyo 189-0022 / JP
04 / SASAKI, Hirotaka
Higashimurayama-shi, Tokyo 189-0022 / JP
05 / OGAMINO, Takahisa
Higashimurayama-shi, Tokyo 189-0022 / JP
06 / USUDA, Kosuke
Higashimurayama-shi, Tokyo 189-0022 / JP
07 / OKUDA, Ayumu
Higashimurayama-shi, Tokyo 189-0022 / JP
08 / ISHIWATA, Hiroyuki
Higashimurayama-shi, Tokyo 189-0022 / JP
09 / TABUNOKI, Yuichiro
Higashimurayama-shi, Tokyo 189-0022 / JP
10 / NISHII, Keigo
Higashimurayama-shi, Tokyo 189-0022 / JP
Representative(s)Hartz, Nikolai
Wächtershäuser & Hartz
Patentanwaltspartnerschaft mbB
Weinstrasse 8
80333 München / DE
[2022/06]
Application number, filing date20784568.630.03.2020
[2022/06]
WO2020JP14475
Priority number, dateJP2019006823329.03.2019         Original published format: JP 2019068233
[2022/06]
Filing languageJA
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2020203950
Date:08.10.2020
Language:JA
[2020/41]
Type: A1 Application with search report 
No.:EP3950063
Date:09.02.2022
Language:EN
[2022/06]
Search report(s)International search report - published on:JP08.10.2020
(Supplementary) European search report - dispatched on:EP28.10.2022
ClassificationIPC:C07D471/04, C07D519/00, A61P35/00, A61P35/02, A61P43/00, A61K31/437, A61K31/4427, A61K31/506, A61K31/5377, A61K31/5386
[2022/48]
CPC:
A61P35/00 (EP,KR); C07D471/04 (EP,KR,US); A61K31/444 (KR);
A61K31/5377 (KR); A61K31/5386 (KR); A61P35/02 (EP);
A61P43/00 (EP); C07D519/00 (EP,US) (-)
Former IPC [2022/06]A61P35/00, A61P35/02, A61P43/00, C07D471/04, C07D519/00, A61K31/437, A61K31/4427, A61K31/506, A61K31/5377, A61K31/5386
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2022/06]
TitleGerman:NEUARTIGES AZAINDOLDERIVAT[2022/06]
English:NOVEL AZAINDOLE DERIVATIVE[2022/06]
French:NOUVEAU DÉRIVÉ DE L'AZAINDOLE[2022/06]
Entry into regional phase29.09.2021Translation filed 
29.09.2021National basic fee paid 
29.09.2021Search fee paid 
29.09.2021Designation fee(s) paid 
29.09.2021Examination fee paid 
Examination procedure29.09.2021Examination requested  [2022/06]
06.04.2022Amendment by applicant (claims and/or description)
26.05.2023Application deemed to be withdrawn, date of legal effect  [2023/45]
20.06.2023Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2023/45]
Fees paidRenewal fee
31.03.2022Renewal fee patent year 03
Penalty fee
Additional fee for renewal fee
31.03.202304   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[A]WO2008063888  (PLEXXIKON INC [US], et al) [A] 1-14* paragraph [0005] - paragraph [0006]; claim 1 *;
 [A]WO2013142427  (PLEXXIKON INC [US]) [A] 1-14 * paragraph [0286] - paragraph [0289]; claim 1 *
International search[A]JP2017531678  (JANSSEN PHARMACEUTICA NV) [A] 1-14 * , claims, paragraph [0001] *;
 [A]JP2018524381  (GENZYME CORP.) [A] 1-14 * , claims, paragraph [0002], examples 1-56, 1-58 *;
 [A]  - Barberis Claude, Pribish James, Tserlin Elina, Gross Alexandre, Czekaj Mark, Barragué Matthieu, Erdman Paul, Maniar Sachin, Jiang John, Fire Luke, Patel Vinod, Hebert Andrew, Levit Mikhail, Wang Anlai, Sun Frank, Huang Shih-Min A., "Discovery of N-substituted 7- azaindoles as Pan-PIM kinases inhibitors -Lead optimization- Part III", Bioorganic & Medicinal Chemistry Letters, (20190201), vol. 29, no. 3, doi:10.1016/j.bmcl.2018.12.015, ISSN 0960-894X, pages 491 - 495, XP055849713 [A] 1-14 * , in particular, abstract, scheme 2, table 1 *

DOI:   http://dx.doi.org/10.1016/j.bmcl.2018.12.015
 [A]  - Tlabo C. Leboho, Giri Somnath, Popova Inessa, Cock Ian, Michael Joseph P., De Koning Charles B., "Double Sonogashira reactions on dihalogenated aminopyridines for the assembly of an array of 7-azaindoles bearing triazole and quinoxaline substituents at C-5: Inhibitory bioactivity against Giardia duodenalis trophozoites", Bioorganic & Medicinal Chemistry, (20150520), vol. 23, no. 15, ISSN 0968-0896, pages 4943 - 4951, XP055752381 [A] 1-14 * , in particular, scheme 1 *

DOI:   http://dx.doi.org/10.1016/j.bmc.2015.05.024
by applicantWO2005062795
 WO2006009755
 WO2009075344
 WO2011107553
    - Critical Reviews in Clinical Laboratory Sciences, (20120000), vol. 49, pages 49 - 61
    - Current Opinion in Immunology, (20060000), vol. 18, pages 39 - 48
    - New England Journal of Medicine, (20150000), vol. 373, pages 428 - 437
    - Cell, (20100000), vol. 141, pages 39 - 51
    - Frontiers in Immunology, (20140000), vol. 5, no. 489, pages 1 - 15
    - Current Opinion in Pharmacology, (20150000), vol. 23, pages 45 - 51
    - Proc. Natl. Acad. Sci. USA, (20060000), vol. 103, pages 690 - 695
    - Proc. Natl. Acad. Sci. USA, (19900000), vol. 87, pages 1377 - 1380
    - Nature Medicine, (20100000), vol. 16, pages 580 - 585
    - "Progress in Medicine", Life Science Medica, (19850000), vol. 5, pages 2157 - 2161
    - "Pharmaceutical Research and Development", Molecular Design, Hirokawa Publishing Inc, (19900000), vol. 7, pages 163 - 198
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.